CRISPR Technology

GPTKB entity

Statements (63)
Predicate Object
gptkbp:instance_of gptkb:Genetics
gptkbp:allows gene replacement
gene insertion
targeted gene knockout
gptkbp:associated_with ethical concerns
germline editing
off-target effects
gptkbp:based_on bacterial immune system
gptkbp:can_lead_to biodiversity conservation
crop improvement
genetic diseases treatment
gptkbp:developed_by gptkb:Emmanuelle_Charpentier
gptkb:Jennifer_Doudna
2010s
gptkbp:first_described_by gptkb:2012
gptkbp:first_introduced human cells
animal cells
plant cells
gptkbp:future_prospects food security
personalized medicine
disease eradication
gptkbp:has_applications_in agriculture
therapeutics
industrial biotechnology
gptkbp:has_limitations regulatory issues
delivery methods
target specificity
https://www.w3.org/2000/01/rdf-schema#label CRISPR Technology
gptkbp:impact gptkb:biotechnology
gptkb:Medicine
agriculture
gptkbp:invention gptkb:University_of_California
gptkb:Broad_Institute
gptkbp:is_based_on Cas9 protein
guide RNA
gptkbp:is_challenged_by gptkb:public_opinion
ethical debates
scientific skepticism
gptkbp:is_explored_in gptkb:academic_research
clinical settings
commercial applications
gptkbp:is_part_of biotechnology innovations
scientific research advancements
genome editing tools
gptkbp:is_recognized_by gptkb:Nobel_Prize_in_Chemistry
gptkb:National_Academy_of_Sciences
gptkbp:is_subject_to regulatory scrutiny
patent disputes
gptkbp:is_supported_by gptkb:venture_capital
government funding
philanthropic donations
gptkbp:is_used_in clinical trials
agricultural products
gptkbp:originated_in gptkb:Biology
gptkbp:related_to gptkb:gene_therapy
gptkb:biotechnology
molecular biology
gptkbp:used_for biomedical research
agricultural biotechnology
gene editing
genome modification
gptkbp:bfsParent gptkb:Synthetic_Biology
gptkbp:bfsLayer 3